Adding Life to Your Patients' Years Adding Life to Your Patients' Years
Is it enough to just help adults live longer? Lifestyle medicine can add life instead of just years.Medscape Family Medicine (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 22, 2024 Category: Cardiology Tags: Family Medicine/Primary Care Commentary Source Type: news
Heart Failure, Not Stroke, Most Common Complication of A-Fib Heart Failure, Not Stroke, Most Common Complication of A-Fib
A new study found the lifetime risks of post-AF stroke, ischemic stroke, and myocardial infarction improved remained high, with virtually no improvement in the lifetime risk for heart failure.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 22, 2024 Category: Cardiology Tags: Internal Medicine News Source Type: news
Are Carbs Really the Enemy? Are Carbs Really the Enemy?
Our diet hasn ' t necessarily adapted to the ready food supply, which has changed over the years. Caroline Apovian, MD, explains why we need carbs and which ones are best.Medscape Diabetes & Endocrinology (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 19, 2024 Category: Cardiology Tags: Diabetes & Endocrinology Commentary Source Type: news
How Can Doctors Best Assess Worsening Dengue Cases? How Can Doctors Best Assess Worsening Dengue Cases?
It is important to inform patients about warning signs such as abdominal pain, repeated vomiting, decreased urine output, or dizziness when standing, says an epidemiologist.Medscape Infectious Diseases (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 18, 2024 Category: Cardiology Tags: Infectious Diseases Expert Interview Source Type: news
Complete Revasc Not Superior to Culprit-Only PCI After MI Complete Revasc Not Superior to Culprit-Only PCI After MI
In patients with STEMI and multivessel disease, FFR-guided complete nonculprit revascularization did not reduce events vs culprit lesion-only PCI in the FULL-REVASC trial.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 18, 2024 Category: Cardiology Tags: Cardiology News Source Type: news
Correlation Is Not Causation, Wink, Is Not Good Enough Correlation Is Not Causation, Wink, Is Not Good Enough
Cardiology researchers Bob Harrington and Bobby Yeh discuss how to do better observational research and the controversial notion of making causal inferences from such data.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2024 Category: Cardiology Tags: Cardiology Expert Interview Source Type: news
Alcohol-Mediated Renal Denervation Promising in Hypertension Alcohol-Mediated Renal Denervation Promising in Hypertension
Alcohol-mediated renal denervation significantly reduced 24-hour ambulatory systolic blood pressure in uncontrolled hypertension, the sham-controlled TARGET BP I trial showed.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2024 Category: Cardiology Tags: Cardiology News Source Type: news
Pregnancy Complications Increase Risk for Early Death Pregnancy Complications Increase Risk for Early Death
The findings show a need for better care of previously pregnant patients, years after giving birth.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2024 Category: Cardiology Tags: Family Medicine/Primary Care News Source Type: news
Exercise Plus Protein Boosts TAVR Outcomes in Frail Patients Exercise Plus Protein Boosts TAVR Outcomes in Frail Patients
A home-based exercise program plus protein supplements was safe for frail older TAVR patients and improved strength, mobility, and balance vs TAVR alone in PERFORM-TAVR.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2024 Category: Cardiology Tags: Cardiology News Source Type: news
Cardiac Arrhythmia Common at High Altitude Cardiac Arrhythmia Common at High Altitude
More than one in three healthy adults developed cardiac arrhythmias, most commonly bradyarrhythmias, while climbing Mount Everest, a study found.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2024 Category: Cardiology Tags: Cardiology Clinical Summary Source Type: news
Alt Salt May Cut All-Cause and Cardiovascular Mortality Alt Salt May Cut All-Cause and Cardiovascular Mortality
Use of potassium-rich salt substitutes for food preparation could be a boon for public health, a new study found.MDedge News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 17, 2024 Category: Cardiology Tags: Internal Medicine News Source Type: news
Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit Chelation Therapy and CV Risk: Why TACT2 Showed No Benefit
Tricia Ward interviews Gervasio Lamas TACT2, a trial of chelation therapy to lower CV risk presented at the 2024 ACC Scientific Sessions, and why its findings differed from those of TACT.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 16, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
Neutral Result With Novel Agent in Diabetic Cardiomyopathy Neutral Result With Novel Agent in Diabetic Cardiomyopathy
The ARISE-HF trial testing aldose reductase inhibition in asymptomatic diabetic cardiomyopathy did not meet its endpoint but hints at a mechanism that might prevent it.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 16, 2024 Category: Cardiology Tags: Cardiology News Source Type: news
Single-Dose Zilebesiran Cuts BP Out to 6 Months: KARDIA-2 Single-Dose Zilebesiran Cuts BP Out to 6 Months: KARDIA-2
This phase 2 study supports the potential for combining biannual dosing of zilebesiran with standard-of-care antihypertensives to achieve additive blood pressure reductions.Medscape Medical News (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 15, 2024 Category: Cardiology Tags: Cardiology News Source Type: news
EMPACT-MI: Another SGLT2 Inhibitor Miss Post-MI EMPACT-MI: Another SGLT2 Inhibitor Miss Post-MI
Empagliflozin added to standard care did not improve outcomes in post-MI patients at risk for heart failure. John Mandrola, MD, sees the diminishing returns for add-on drugs as positive for patients.theheart.org on Medscape (Source: Medscape Cardiology Headlines)
Source: Medscape Cardiology Headlines - April 12, 2024 Category: Cardiology Tags: Cardiology Commentary Source Type: news
